Targeting tumor-stromal interactions in bone metastasis

Area of Science:

• Oncology
• Cell Biology
• Cancer Metastasis

Background:

• Bone metastasis is common in advanced solid tumors like breast, prostate, and lung cancers.
• The molecular mechanisms driving bone metastasis are increasingly understood, highlighting the critical role of the tumor microenvironment.

Purpose of the Study:

• To review the multifaceted contributions of host stromal cells to the bone metastatic cascade.
• To identify current and emerging therapeutic targets for bone metastasis based on tumor-stromal interactions.

Main Methods:

• Literature review of recent research on bone metastasis and host-stromal cell interactions.
• Analysis of molecular mechanisms involved in pre-metastatic niche formation, seeding, dormancy, and immune evasion.

Main Results:

• Host stromal cells (platelets, endothelial cells, immune cells, mesenchymal cells) are crucial at all stages of bone metastasis.
• Key molecular players include integrins, TGFβ family members, bone resident proteins, RANKL, and PTHrP.
• Tumor-stromal interactions influence niche conditioning, seeding, dormancy, bone remodeling, immune suppression, and chemotherapy resistance.

Conclusions:

• Targeting tumor-stromal interactions offers promising therapeutic strategies for bone metastasis.
• Future research should focus on leveraging these interactions to develop novel treatments beyond traditional bone remodeling inhibitors.